System for producing cultivated meats, tissues and associated products from cells

1. A system for in vitro meat production comprising:

at least one bioreactor, wherein the at least one bioreactor comprises a sterile bioreactor configured to hold a fluid and at least one type of cells to form tissue, wherein the sterile bioreactor comprises a second solid phase support separated from a first solid phase support by a mesh, wherein the second solid phase support is configured to contain bioengineered cells configured to secrete nutrients, growth factors, and cytokines for bioengineered cells growing on the second solid phase support in situ, wherein the second solid phase support is further configured to physically separate the bioengineered cells from at least one type of cells on the first solid phase support;

a dialysis device comprising a dialysis membrane configured to replenish nutrients to the cells and remove metabolic waste from the sterile bioreactor to dialysate;

a fresh medium device connected to the dialysis unit device and configured to supply the dialysate to the dialysis device; and

a waste removal device connected to the fresh medium device and configured to remove the metabolic waste from the dialysate, wherein the waste removal device is physically separated from the sterile bioreactor and the fresh medium device;

wherein the dialysate comprises nutrients for the cells,

wherein the metabolic waste comprises ammonia and lactate,

wherein the waste removal device comprises a first biocatalyst configured to breakdown ammonia,

wherein the waste removal device comprises a second biocatalyst configured to breakdown lactate to pyruvate, thereby generating fresh carbon sources to promote cell growth in the sterile bioreactor,

wherein the sterile bioreactor, the dialysis device, the fresh medium device and the waste removal device are detachably connected to each other and connected to the system via aseptic connectors.

2. The system of claim 1 , wherein the second biocatalyst is an enzyme configured to break down lactate.

3. The system of claim 1 , wherein the first biocatalyst is nitrifying bacteria.

4. The system of claim 1 , wherein the dialysis membrane is at least one 500 Daltons (Da) molecular weight cut-off (MWCO) membrane, wherein the membrane is selected from Cellulose Ester (CE), Regenerated Cellulose (RC), and Polyvinylidene fluoride (PVDF).

5. The system of claim 4 , wherein dialysis membrane is configured to retain macromolecules in the sterile bioreactor, wherein the macromolecules comprise one or more of the following: proteins having a molecular weight of at least 100 Da, phospholipids, lipids, polysaccharides, proteoglycans, nucleic acids, insulin-like growth factor and transforming growth factor-beta.

6. The system of claim 1 , wherein the at least one bioreactor comprises a second bioreactor, wherein the sterile bioreactor and the second bioreactor are connected in parallel.

7. The system of claim 1 , wherein the sterile bioreactor further comprises

one or more platforms for cells to grow three-dimensionally thereon, wherein each of the one or more platforms is an edible scaffold or extracellular matrix; and

a holder configured to receive and hold said one or more platforms.

8. The system of claim 1 , wherein the sterile bioreactor is configured to support cell growth in suspension or on microcarriers on the first solid phase support, the second solid phase support, or both.

9. The system of claim 1 , further comprising a pump and a tube connected to the sterile bioreactor, wherein the pump is configured to create a fluid flow that evenly distributes nutrients in the fluid inside the sterile bioreactor in the absence of a stirrer or agitator in the system.